VORASIDENIB

0 reported adverse events

Drug classes: Isocitrate Dehydrogenase 1 Inhibitor [EPC] Isocitrate Dehydrogenase 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking VORASIDENIB:

# Side effect Count
See all common reactions for VORASIDENIB

VORASIDENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for VORASIDENIB